All Title Author
Keywords Abstract

Renal Replacement Therapy in Acute Kidney Failure due to Rhabdomyolysis

DOI: 10.1155/2012/603849

Full-Text   Cite this paper   Add to My Lib


Rhabdomyolysis is a syndrome caused by skeletal muscle cells destruction which can occur for many reasons, including prolonged immobilization. The main complication of the syndrome is the development of acute renal failure. Rhabdomyolysis and myoglobinuria are responsible for approximately 5% of all causes of acute renal failure in the USA. The cause of rhabdomyolysis is often multifactorial, and approximately 8–20% of such patients develop myoglobinuric acute renal failure. 1. Introduction Rhabdomyolysis is characterized by muscle cell destruction and the subsequent leakage of muscle cell contents, including electrolytes, sarcoplasmic myoglobin, and other proteins into the circulation [1]. Acute kidney injury is a potential complication of severe rhabdomyolysis [2], and the prognosis is much worse if renal failure develops when the main cause is any trauma [3, 4]. In spite of the fact that conventional hemodialysis filters do not remove myoglobin, hemodiafiltration with super-high-flux dialyzers may be effective [5]. Our aim is to report a case of acute kidney injury due to rhabdomyolysis in which we used continuous venovenous hemodiafiltration (CVVH) in the intensive care unit of a tertiary university hospital. 2. Case Presentation An 82-year-old woman, independent as regards activities of daily life, was admitted into the emergency department due to accidental fall at home with consecutive immobilization for a period of approximately 12 hours. Her medical history includes hypertension, dyslipidemia, non-insulin-dependent diabetes, and mild chronic renal insufficiency (baseline creatinine 1.4?mg/dL). The accidental fall caused right femur periprosthetic supracondylar fracture, which is pending surgery. Blood sample analysis at admission was the following: creatinine 8.74?mg/dL, urea 210?mg/dL with anuria compatible with kidney injury according to RIFLE criteria [6], and the patient was transferred to the intensive care unit (ICU). At the time of admission to the ICU, blood sample analysis showed the following: creatinine 8.76?mg/dL, urea 202?mg/dL, and potassium 6.4?mEq/L, and arterial blood gas analysis showed metabolic acidosis: pH 7.02, ?24.6 base excess, serum bicarbonate 4.3?mEq/L, partial pressure of oxigen 79?mmHg and partial pressure of carbon dioxide 16.9 mmHg of creatine phosphokinase (CK) 9475?U/L, with oliguria. Continuous venovenous hemofiltration (CVVHF) with (Edwards Aquarius, Irvine-based Edwards Lifesciences Corp. Lone Peak Parkway, Draper, UT?84020, USA Irvine, CA, USA) 1,2 polysulphone m2 membrane was started with the sequent


[1]  F. G. O'Connor and P. A. Deuster, “Rhabdomyolysis,” in Cecil Medicine, L. Goldman and D. Ausiello, Eds., chapter 114, Saunders Elsevier, Philadelphia, Pa, USA, 23rd edition, 2007.
[2]  G. Remuzzi, N. Perico, and M. E. DeBroe, “Acute kidney injury,” in Brenner and Rector's the Kidney, B. M. Brenner, Ed., chapter 29, Saunders Elsevier, Philadelphia, Pa, USA, 8th edition, 2007.
[3]  W. H. Bagley, H. Yang, and K. H. Shah, “Rhabdomyolysis,” Internal and Emergency Medicine, vol. 2, no. 3, pp. 210–218, 2007.
[4]  S. G. Holt and K. P. Moore, “Pathogenesis and treatment of renal dysfunction in rhabdomyolysis,” Intensive Care Medicine, vol. 27, no. 5, pp. 803–811, 2001.
[5]  T. Naka, D. Jones, I. Baldwin et al., “Myoglobin clearance by super high-flux hemofiltration in a case of severe rhabdomyolysis: a case report,” Critical Care, vol. 9, no. 2, pp. R90–R95, 2005.
[6]  R. Bellomo, C. Ronco, J. A. Kellum, R. L. Mehta, and P. Palevsky, “Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group,” Critical care, vol. 8, no. 4, pp. R204–R212, 2004.
[7]  J. P. Knochel, “Rhabdomyolysis and myoglobinuria,” Annual Review of Medicine, vol. 33, pp. 435–443, 1982.
[8]  R. A. Zager and L. M. Gamelin, “Pathogenetic mechanisms in experimental hemoglobinuric acute renal failure,” The American journal of physiology, vol. 256, no. 3, pp. F446–F455, 1989.
[9]  R. A. Zager, “Studies of mechanisms and protective maneuvers in myoglobinuric acute renal injury,” Laboratory Investigation, vol. 60, no. 5, pp. 619–629, 1989.
[10]  R. A. Zager and C. A. Foerder, “Effects of inorganic iron and myoglobin on in vitro proximal tubular lipid peroxidation and cytotoxicity,” Journal of Clinical Investigation, vol. 89, no. 3, pp. 989–995, 1992.
[11]  G. Melli, V. Chaudhry, and D. R. Cornblath, “Rhabdomyolysis: an evaluation of 475 hospitalized patients,” Medicine, vol. 84, no. 6, pp. 377–385, 2005.
[12]  M. M. Ward, “Factors predictive of acute renal failure in rhabdomyolysis,” Archives of Internal Medicine, vol. 148, no. 7, pp. 1553–1557, 1988.
[13]  Y. Wakabayashi, T. Kikuno, T. Ohwada, and R. Kikawada, “Rapid fall in blood myoglobin in massive rhabdomyolysis and acute renal failure,” Intensive Care Medicine, vol. 20, no. 2, pp. 109–112, 1994.
[14]  S. Holt, B. Reeder, M. Wilson et al., “Increased lipid peroxidation in patients with rhabdomyolysis,” Lancet, vol. 353, no. 9160, p. 1241, 1999.
[15]  T. S. Mikkelsen and P. Toft, “Prognostic value, kinetics and effect of CVVHDF on serum of the myoglobin and creatine kinase in critically ill patients with rhabdomyolysis,” Acta Anaesthesiologica Scandinavica, vol. 49, no. 6, pp. 859–864, 2005.
[16]  M. S. Sever, R. Vanholder, and N. Lameire, “Management of crush-related injuries after disasters,” New England Journal of Medicine, vol. 354, no. 10, pp. 1052–1063, 2006.
[17]  K. P. Moore, S. G. Holt, R. P. Patel et al., “A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure,” Journal of Biological Chemistry, vol. 273, no. 48, pp. 31731–31737, 1999.
[18]  O. S. Better and J. H. Stein, “Current concepts: early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis,” New England Journal of Medicine, vol. 322, no. 12, pp. 825–829, 1990.
[19]  A. L. Huerta-Alardín, J. Varon, and P. E. Marik, “Bench-to-bedside review. Rhabdomyolysis—an overview for clinicians,” Critical Care, vol. 9, no. 2, pp. 158–169, 2005.
[20]  X. Bosch, E. Poch, and J. M. Grau, “Rhabdomyolysis and acute kidney injury,” New England Journal of Medicine, vol. 361, no. 1, pp. 10–72, 2009.
[21]  C. Ronco, “Extracorporeal therapies in acute rhabdomyolysis and myoglobin clearance,” Critical Care, vol. 9, no. 2, pp. 141–142, 2005.
[22]  A. Brendolan, V. D'Intini, Z. Ricci et al., “Pulse high volume hemofiltration,” International Journal of Artificial Organs, vol. 27, no. 5, pp. 398–403, 2004.


comments powered by Disqus